Nebula genomics strengthens advisory board with appointment of russ altman, m.d., ph.d.

Garden city, ny, oct. 17, 2022 (globe newswire) -- prophase labs, inc. (nasdaq: prph), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly owned subsidiary, nebula genomics, inc., has added russ b. altman, m.d., ph.d to its advisory board. dr. altman is the kenneth fong professor of bioengineering, genetics, medicine, biomedical data science and computer science, and past chair of the bioengineering department at stanford university. dr. altman is the second member of nebula's advisory board and joins dr. george church, nebula's founder and advisory board chairman. nebula genomics, a global leader in direct-to-consumer whole genome sequencing, has achieved significant year over year growth. dr. altman's expertise will support continued expansion through thought leadership, industry knowledge and strategic guidance.
PRPH Ratings Summary
PRPH Quant Ranking